Jintian Hu

Dr. Jintian Hu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2021 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
YLYi-Lin Li
Yi-Lin Li
ZLZe-Hui Mm Li
Ze-Hui Mm Li
XCXue-Ying Chen
Xue-Ying Chen
WXWen-Shan Xing
Wen-Shan Xing
JHJintian Hu
Jintian Hu
Background: Facial thread lifting technology has been applied for more than 30 years, with relatively few complications. In 2014, China approved polydioxanone thread (an absorbable barbed thread) for large-scale nonsurgical facial lifting. However, due to surgeons’ lack of overall experience, the complications of polydioxanone thread facelift have been relatively high. Methods: From April 2014 to January 2020, a total of 190 patients with postoperative complications of facelifts were treated after they underwent thread lifting in other hospitals. Of these, 189 patients were women and one was a man; the age of patients ranged from 28 to 62 years, with an average age of 37.4 years. Results: Patients were mainly treated in our outpatient clinic for the following complications: skin dimpling (77 cases, 40.5%); contour irregularity (32 cases, 16.8%); visible threads (31 cases, 16.3%); thread extrusion (10 cases, 5.3%); infection (17 cases, 8.9%); swelling (nine cases, 4.7%); incomplete facial paralysis (five cases, 2.6%); hyperpigmentation (four cases, 2.1%); hematoma (four cases, 2.1%); allergy (one case, 0.05%). Follow-up was scheduled 1–24 weeks after treatment. Conclusions: The most common complications of facial thread lifting are, in the following order, skin dimpling, contour irregularity, visible threads, and thread extrusion. The reasons for complications are mainly unfamiliarity with facial anatomy, unskilled surgical operation, and misunderstanding of the facial aesthetics of Asian women.

14 June 2022 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
LJLiya Jiang
Liya Jiang
LYLi Yuan
Li Yuan
ZLZehui Li
Zehui Li
XSXueshang Su
Xueshang Su
JHJintian Hu
Jintian Hu
HCHongli Chai
Hongli Chai

1 August 2025 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
RORonghao Ouyang
Ronghao Ouyang
XSXueshang Mm Su
Xueshang Mm Su
YLYutong Mm Liang
Yutong Mm Liang
SLShunbing Mm Lu
Shunbing Mm Lu
ZZZiming Mm Zhang
Ziming Mm Zhang
JHJintian Hu
Jintian Hu
Background: Poly-l-lactic acid (PLLA) has gained popularity as a cosmetic injectable filler due to its excellent biocompatibility and capacity for long-term collagen stimulation. Despite widespread clinical use, a comprehensive evaluation of recent advancements and updated clinical techniques is essential for improving facial rejuvenation outcomes and minimizing complications. Methods: A comprehensive literature review was conducted through databases including PubMed and Web of Science. We analyzed recent advancements, clinical efficacy, safety profiles, injection techniques, and comparative advantages of PLLA relative to other fillers. The review emphasized clinical trial outcomes, practical injection recommendations, and management strategies for common and rare complications. Results: Recent clinical studies confirmed the effectiveness of PLLA in treating facial wrinkles, volume loss, and enhancing skin elasticity and hydration, with patient satisfaction exceeding 90%. Novel injection techniques such as ultrasound guidance and needle-free microjet injection have improved safety and patient satisfaction. Technological innovations, including particle-size optimization and composite formulations, have further enhanced the biocompatibility, efficacy, and duration of effect of PLLA, significantly reducing adverse events. Conclusions: PLLA injections offer safe, long-lasting, and natural rejuvenation outcomes for facial and neck areas. Continuous innovation in injection technologies, particle formulations, and combination therapies promises further enhancements. Future research should focus on individualized treatment protocols, optimizing long-term safety and efficacy, and expanding PLLA applications through advanced biomaterials and regenerative approaches.

6 March 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
ZLZehui Li
Zehui Li
HWHuanhuan Wu
Huanhuan Wu
ZYZheng Yang
Zheng Yang
YXYujian Xu
Yujian Xu
JXJiahua Xing
Jiahua Xing
JHJintian Hu
Jintian Hu

1 August 2023 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
JZJun Zhuang
Jun Zhuang
QZQiaoyuan Zheng
Qiaoyuan Zheng
XSXueshang Su
Xueshang Su
LJLiya Jiang
Liya Jiang
JHJintian Hu
Jintian Hu
Background: Embolism is a serious complication after facial filling, with a usually poor prognosis of the symptoms after embolism. The authors systematically reviewed reported cases of facial vascular embolism, explored the relationship between the location and material used for facial filling and occurrence of vascular embolism, and assessed the prognosis of complications after vascular embolism. Methods: This study provides a systematic review of published cases of vascular embolism after facial filling. A summary of the filling materials and filling sites for each case, the adverse reactions and embolized blood vessels, a recording of the time when each patient experienced adverse reactions and started treatment, and a presentation of their prognosis are provided. Results: The frontal, eyebrow, and nose are common filling sites causing facial embolism. The main clinical manifestations after embolism were visual impairment, skin necrosis, and ptosis. The prognosis of visual impairment after embolization was poor, whereas skin necrosis and ptosis generally improved after treatment. Conclusions: This article aimed to review the clinical manifestations, therapies, and prognosis of embolism after facial filling. A better understanding of these complications can help clinicians to detect the occurrence of complications as early as possible and give patients timely treatment.

10 October 2022 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
JZJun Mm Zhuang
Jun Mm Zhuang
YCYoubai Chen
Youbai Chen
JHJintian Hu
Jintian Hu
Using stem cell exosomes to treat alopecia is a new treatment in plastic surgery. However, there are few reports on the complications of this treatment. This study describes a method of using 5-fluorouracil combined with triamcinolone acetonide to treat allergic reactions caused by stem cell exosomes injection. The ultrasound results before treatment showed that the thickness of subcutaneous soft tissue in the forehead was 0.35 cm,the length and short diameter of left retroauricular lymph nodes were 1.11 and 0.46 cm, and the length and short diameter of right retroauricular lymph nodes were 1.10 and 0.45 cm. After treatment, the thickness of subcutaneous soft tissue in the forehead was 0.20 cm, the length and short diameter of the lymph nodes behind the left ear were 1.06 and 0.40 cm, respectively, and the length and short diameter of the lymph nodes behind the right ear were 1.06 and 0.36 cm, respectively. The results of treatment proved that this treatment had a therapeutic effect on the allergy of patients.